Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT06687499Phase 4Completed
14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection
Drug Resistance, MultipleHelicobacter Pylori
StudydirectorStart date: 2022-08-22
Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis
Anemia, PerniciousAutoimmune DiseasesGastritis, Atrophic+2 more
PrincipalinvestigatorStart date: 2022-01-01
NCT06687473Phase 4Completed
Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains
Drug Resistance, MultipleHelicobacter PyloriVirulence Factor
StudydirectorStart date: 2022-01-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06687499Phase 4StudyDirector

14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection

Drug Resistance, MultipleHelicobacter Pylori
Completed
NCT05238181PrincipalInvestigator

Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis

Anemia, PerniciousAutoimmune DiseasesGastritis, Atrophic+2 more
Unknown
NCT06687473Phase 4StudyDirector

Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains

Drug Resistance, MultipleHelicobacter PyloriVirulence Factor
Completed

All 3 trials loaded